Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
BridgeBio Pharma, Inc. (BBIO) had Current Assets of $1.09B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$243.68M |
|
$-152.22M |
|
$15.05M |
|
$228.63M |
|
$350.75M |
|
$-107.08M |
|
$-48.81M |
|
$-155.89M |
|
$-155.89M |
|
$-155.89M |
|
$-155.89M |
|
$-155.89M |
|
$-155.89M |
|
$-107.08M |
|
$-104.10M |
|
195.79M |
|
195.79M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
|
Current Assets |
$1.09B |
$5.23M |
|
$124.16M |
|
$1.22B |
|
$890.65M |
|
$1.93B |
|
$2.83B |
|
$3.72B |
|
$-2.50B |
|
$-2.53B |
|
$-2.50B |
|
195.28M |
|
| Cash Flow Statement Financials | |
$-268.38M |
|
$-24.85M |
|
$401.12M |
|
$572.14M |
|
$680.04M |
|
$107.90M |
|
$77.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
-3.34 |
|
-0.99 |
|
93.83% |
|
-43.94% |
|
-43.94% |
|
-- |
|
-63.97% |
|
-62.47% |
|
$-268.89M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.28 |
|
0.96 |
|
93.99 |
|
6.22% |
|
6.16% |
|
-12.81% |
|
27.00% |
|
$-12.83 |
|
$-1.37 |
|
$-1.37 |
|